Correlation Between Immix Biopharma and Sharps Technology

Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Sharps Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Sharps Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immix Biopharma and Sharps Technology, you can compare the effects of market volatilities on Immix Biopharma and Sharps Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Sharps Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Sharps Technology.

Diversification Opportunities for Immix Biopharma and Sharps Technology

0.58

Correlation Coefficient

Immix Biopharma  Sharps Technology

Very weak diversification

The 3 months correlation between Immix and Sharps is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Sharps Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sharps Technology and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Sharps Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sharps Technology has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Sharps Technology go up and down completely randomly.

Pair Corralation between Immix Biopharma and Sharps Technology

Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.6 times more return on investment than Sharps Technology. However, Immix Biopharma is 1.65 times less risky than Sharps Technology. It trades about 0.1 of its potential returns per unit of risk. Sharps Technology is currently generating about 0.04 per unit of risk. If you would invest  203.00  in Immix Biopharma on May 5, 2025 and sell it today you would earn a total of  62.00  from holding Immix Biopharma or generate 30.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Immix Biopharma  vs.  Sharps Technology

Immix Biopharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Sharps Technology

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sharps Technology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Sharps Technology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Immix Biopharma and Sharps Technology

The main advantage of trading using opposite Immix Biopharma and Sharps Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Sharps Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sharps Technology will offset losses from the drop in Sharps Technology's long position.

The idea behind Immix Biopharma and Sharps Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.